CN Patent

CN111372920B — N-(4-(4-(环丙基甲基)哌嗪-1-羰基)苯基)喹啉-8-磺酰胺的结晶形式

Assigned to Agios Pharmaceuticals Inc · Expires 2023-10-20 · 3y expired

What this patent protects

本文提供了下式的无定形和结晶半硫酸盐形式。还提供了包含无定形和结晶半硫酸盐形式的药物组合物，其制备方法及其在治疗与丙酮酸激酶相关的病症例如丙酮酸激酶缺乏症中的用途。

USPTO Abstract

本文提供了下式的无定形和结晶半硫酸盐形式。还提供了包含无定形和结晶半硫酸盐形式的药物组合物，其制备方法及其在治疗与丙酮酸激酶相关的病症例如丙酮酸激酶缺乏症中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111372920B
Jurisdiction
CN
Classification
—
Expires
2023-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.